Core Points - The company, Elis, disclosed the purchase of its own shares on October 24, 2025, as part of its buyback program authorized by the General Shareholders' Meeting on May 22, 2025 [2] - A total of 3,047 shares were acquired at a weighted average price of €24.76 per share [2] - The purpose of the share buyback is to cover maturing performance share plans and allocate free shares to employees under the Elis for All 2025 international employee shareholding plan, as well as to cancel shares in accordance with the resolution from the Combined General Meeting [2]

Core Insights - Shares in Ethereum treasury firm ETHZilla (ETHZ) surged 14% on Monday, continuing gains from the previous week, driven by interest from a meme stock influencer associated with Beyond Meat (BYND) [1] - Dimitri "Capybara Stocks" Semenikhin, who previously influenced BYND's price spike, has acquired approximately 2.2% of ETHZ's shares and is advocating for changes within the firm [2] - Semenikhin highlighted that ETHZilla's multiplier on net assets was at an all-time low of 50% at the time of his purchase, indicating a significant discount compared to other digital treasuries [2] Company Actions - Semenikhin published an open letter urging ETHZilla's management to utilize its share buyback program more effectively, noting the abnormality of his ability to acquire a large position at a discount to net asset value [3] - In August, ETHZilla announced a $250 million share buyback program aimed at enhancing shareholder value, and Semenikhin is now pushing for the firm to sell some of its Ethereum holdings to fund share repurchases [4] - Following Semenikhin's letter, ETHZilla sold Ethereum and repurchased approximately $40 million worth of shares, with plans to continue repurchases as its market net asset value (mNAV) trades below 1 [4] Financial Position - ETHZilla's chairman and CEO, McAndrew Rudisill, stated that the firm is leveraging its balance sheet strength, including reducing ETH holdings, to execute share repurchases [5] - As of the recent sale, ETHZilla held approximately 102,916 ETH, valued around $434 million, and after the sale, it retains about $400 million in ETH [5]

Core Viewpoint - Artea Bank has successfully completed its share buyback program, acquiring a total of 1,130,250 treasury shares for EUR 930,595.08, reflecting the bank's commitment to enhancing shareholder value [1][3]. Group 1: Buyback Program Details - The buyback program was approved by the Management Board on 1 October 2025, following a decision made at the Ordinary General Meeting of Shareholders on 31 March 2025 [2]. - The program was authorized by the European Central Bank (ECB) on 23 September 2025, allowing the bank to repurchase up to 4,500,000 shares [2]. Group 2: Financial Impact - During the buyback period from 6 October to 24 October 2025, Artea Bank acquired shares at an average price of EUR 0.823 per share [1]. - The total expenditure for the buyback amounted to EUR 930,595.08 [1]. Group 3: Future Outlook - The CFO of Artea Bank, Tomas Varenbergas, indicated that future buyback activities will depend on market conditions and other circumstances [3].

Core Points - Sampo plc has initiated a share buyback program with a maximum value of EUR 200 million, which commenced on 7 August 2025 [1][2] - On 24 October 2025, Sampo plc acquired a total of 293,546 A shares at an average price of EUR 9.73 per share [1] - Following the buybacks, Sampo plc now holds a total of 19,013,931 A shares, representing 0.71% of the total shares outstanding [2] Summary by Category Share Buyback Program - The share buyback program was announced on 6 August 2025 and is in compliance with the Market Abuse Regulation (EU) 596/2014 [1] - The program is based on the authorization granted by Sampo's Annual General Meeting on 23 April 2025 [1] Transaction Details - On 24 October 2025, the daily buyback volumes across different markets were as follows: - AQEU: 5,198 shares at EUR 9.73 - CEUX: 102,429 shares at EUR 9.74 - TQEX: 30,637 shares at EUR 9.73 - XHEL: 155,282 shares at EUR 9.73 - The total buyback volume for the day was 293,546 shares at an average price of EUR 9.73 [1] Ownership Post-Buyback - After the buyback transactions, Sampo plc's total ownership of A shares stands at 19,013,931, which is 0.71% of the total shares [2]

Group 1 - Aktsiaselts Infortar conducted a share buyback program on the Nasdaq Tallinn Stock Exchange from October 20 to October 24, 2025, acquiring a total of 2,024 shares at a weighted average price ranging from EUR 40.8000 to EUR 41.0000 [1] - The share buyback program is managed by SEB Pank AS, which is responsible for executing the transactions on behalf of Aktsiaselts Infortar [1] - Summary data regarding daily volume and weighted average prices will be disclosed within seven trading days following the transactions and will be available to the Estonian Financial Supervision and Resolution Authority [2] Group 2 - Infortar operates in seven countries, focusing on maritime transport, energy, and real estate, with a significant ownership stake in Tallink Grupp (68.47%) and Elenger Grupp (100%) [3] - The company has a modern real estate portfolio of approximately 141,000 square meters and is involved in various sectors including construction, mineral resources, agriculture, and printing [3] - Infortar comprises a total of 110 companies, including 101 subsidiaries, 4 affiliated companies, and 5 subsidiaries of affiliated companies, employing 6,866 people excluding affiliates [3]

Core Insights - Iridium Communications reported Q3 2025 EPS of 35 cents, exceeding Zacks Consensus Estimate by 35% and up from 21 cents in the prior year [1][9] - Quarterly revenues reached $226.9 million, a 7% year-over-year increase, driven by strong service revenue and equipment sales, surpassing the consensus estimate of $224.05 million [2][9] Revenue Breakdown - Total service revenues increased by 3% year over year to $165.2 million, accounting for 73% of total revenues, supported by a growing subscriber base across various sectors [3][4] - Commercial service segment represented 61% of total revenues, with commercial revenue at $138.3 million, a 4% increase, while government service revenue rose 1% to $26.9 million [4][5] - Engineering and support revenues surged 31% to $40.2 million, attributed to increased U.S. government-related projects [6] Subscriber and Market Dynamics - As of September 30, the company had 2,542,000 billable subscribers, a 2% increase from the previous year, with commercial IoT representing 82% of the commercial user base [11] - The communications market is evolving, with new industries exploring satellite solutions, creating a favorable environment for Iridium [2] Financial Outlook - For 2025, Iridium has lowered its full-year service revenue growth forecast to around 3% from the previous 3-5% guidance due to delayed PNT revenue [13] - The company narrowed its OEBITDA guidance to $495–$500 million, at the upper end of its prior range [14] Shareholder Actions - Management paused share buybacks to focus on strategic investments and debt reduction, leading to a 7.48% drop in share price following the announcement [7][9][12]

Core Insights - The company reported a Q3 sales growth of 7.0% at constant exchange rates (CER) and a business earnings per share (EPS) of €2.91, reflecting a strong performance despite a high base of comparison from the previous year [1][4][5] Sales Performance - Newly launched medicines and vaccines contributed significantly, with a growth of 40.8% [4] - Dupixent sales increased by 26.2%, surpassing €4 billion in quarterly global sales for the first time, and €3 billion in the US [4][5] - Overall, IFRS net sales reported for Q3 2025 were €12,434 million, a 2.3% increase, while year-to-date (YTD) sales reached €32,323 million, up 5.9% [8] Financial Metrics - Business EPS rose by 13.2% at CER and 7.0% at actual exchange rates, reaching €2.91 [5][6] - Business operating income for Q3 was €4,445 million, up 2.7%, with a YTD increase of 5.9% [8] - Free cash flow for Q3 was reported at €2,994 million, a decrease of 6.1%, while YTD free cash flow was €5,452 million, an increase of 50.8% [8] Research and Development - The company achieved two regulatory approvals: Wayrilz in the US for immune thrombocytopenia and Tzield in China for delaying the onset of stage 3 type 1 diabetes [7] - Positive phase 3 readouts were reported for amlitelimab in atopic dermatitis and Fluzone HD for influenza in patients aged 50 and above [7] - The company initiated three new phase 3 studies and received three new regulatory designations [7] Strategic Initiatives - The acquisition of Vigil Neuroscience was completed, enhancing the early-stage pipeline [8] - The company committed an additional $625 million to Sanofi Ventures, focusing on innovative biotech and digital health investments [5] - A €5 billion share buyback program is set to be completed by the end of 2025, with 86.1% executed to date [5][8] Guidance and Outlook - The company anticipates high single-digit sales growth at CER for 2025 and a strong business EPS rebound with low double-digit growth at CER before share buyback [4][6]

Core Points - Sampo plc has initiated a share buyback program with a maximum value of EUR 200 million, which commenced on 7 August 2025 [1][2] - On 23 October 2025, Sampo plc acquired a total of 293,404 A shares at an average price of EUR 9.78 per share [1] - Following the transactions, Sampo plc now holds 18,720,385 A shares, representing 0.70% of the total shares outstanding [2] Summary by Sections Share Buyback Program - The share buyback program was announced on 6 August 2025 and is in compliance with the Market Abuse Regulation (EU) 596/2014 [1] - The program is based on the authorization granted by Sampo's Annual General Meeting on 23 April 2025 [1] Transaction Details - On 23 October 2025, the daily buyback volumes were as follows: - 4,300 shares on AQEU - 108,122 shares on CEUX - 28,123 shares on TQEX - 152,859 shares on XHEL - The total buyback volume for the day was 293,404 shares at an average price of EUR 9.78 [1] Ownership Post-Transactions - After the disclosed transactions, Sampo plc's total ownership of A shares stands at 18,720,385, which is 0.70% of the total shares [2]

Core Viewpoint - Capital One Financial Corp. has delivered a strong earnings report, indicating a favorable time for investors to consider buying the stock [3][4]. Financial Performance - The company reported revenue of $15.36 billion, exceeding expectations of $15.06 billion and representing a 23% increase from the previous quarter [5]. - Adjusted earnings per share (EPS) were $5.95, surpassing estimates of $4.25 and showing an 8.5% increase from the prior quarter [5]. - The net interest margin increased to 8.36%, up approximately 75 basis points, with about 45 basis points attributed to the merger with Discover [5]. Shareholder Returns - Capital One announced a new $16 billion share repurchase program, which is nearly 12% of the company's current market cap, replacing the previous program from April 2022 [6]. - The quarterly dividend was increased by 33%, from $0.60 to $0.80 per share, effective with the next distribution [7]. Credit Loss Provisions - The provision for credit losses was reported at $2.71 billion, higher than the $2.48 billion from the same quarter last year, but still smaller than expected [9]. - The net charge-off ratio decreased to 3.16%, down from 3.27% in the same quarter last year [9]. Stock Performance and Analyst Ratings - COF stock rose by 3.39% during midday trading following the earnings news, nearing its all-time high [4]. - The stock is currently trading near the top of its Bollinger band with a relative strength index (RSI) of approximately 58, indicating a mildly bullish setup [8]. - The 12-month stock price forecast is set at $260.00, suggesting a 17.39% upside based on 24 analyst ratings [12]. Market Sentiment - Analysts have raised their price targets for Capital One, with most targets above the consensus price of $258.89 [14]. - Despite a Moderate Buy rating, some top-rated analysts believe there are better investment opportunities available [15].

Financial Data and Key Metrics Changes - CBRE reported a 34% growth in core EPS and a 19% increase in core EBITDA for Q3 2025, exceeding expectations across the board [8][13] - The company raised its full-year core EPS outlook to $6.25 to $6.35 from $6.10 to $6.20, reflecting strong performance and confidence in the fourth quarter [6][13] Business Line Data and Key Metrics Changes - Advisory services revenue grew by 16%, driven by strong performance in leasing and sales, with global leasing revenue rising 17% [8][9] - Property sales business delivered a 28% revenue growth, with notable strength in office, industrial, and data centers [9][10] - The Building Operations & Experience segment saw an 11% revenue growth, supported by work for data center hyperscalers and new client wins [10] - Project management segment revenue increased by 19%, with broad-based double-digit growth across regions [11] Market Data and Key Metrics Changes - Revenue from Japan and India combined rose more than 30% to nearly $400 million, indicating strong growth potential in these markets [6] - U.S. industrial leasing increased by 27%, driven by third-party logistics providers [9] Company Strategy and Development Direction - The company emphasizes its scale and breadth across asset types, client types, and geographies to drive growth and create integrated solutions for clients [5] - CBRE is focusing on M&A and co-investment into real estate investments, prioritizing these over share repurchases [18] - The company is building sustainable businesses in the data center sector, expecting significant growth in this area over the next five years [38][40] Management's Comments on Operating Environment and Future Outlook - Management expects a longer, slower recovery in the sales part of the business, with strong pipelines and pent-up demand from both buyers and sellers [22] - The company anticipates continued strong activity in the fourth quarter, with robust pipelines in leasing and sales [25] - Management noted that real estate has become a more strategic asset class for companies, enhancing the importance of their services [57] Other Important Information - CBRE expects to generate approximately $1.8 billion of free cash flow for the year, with net leverage at 1.2 turns [13] - The company is integrating its operations with Turner & Townsend to enhance service offerings and achieve cost synergies [32] Q&A Session Summary Question: Did anything get pulled forward from Q4 due to Q3 strength? - Management indicated no significant pull forward across segments, but acknowledged tougher comps in Q4 [16] Question: Can you comment on the M&A pipeline? - The company remains focused on M&A and co-investment, looking for well-operated targets that can benefit from being part of CBRE [18] Question: Where are we in the CRE transaction market recovery? - Management expects a steady recovery in investment sales over the next couple of years, driven by pent-up demand [22] Question: How are pipelines trending in the fourth quarter? - Pipelines are strong, with expectations for continued strong activity in leasing and sales [25] Question: Are you appropriately staffed in the advisory segment? - Management stated they are appropriately staffed but are also looking to add talent where necessary [27] Question: What is the outlook for the BOE segment? - Pipelines in the BOE segment are strong, with elevated sales expected to show up in revenue in the second half of next year [47] Question: How do you view the facilities management market? - The company has expanded its total addressable market (TAM) through various acquisitions and believes it can continue to grow in this space [51] Question: What is the constraint for data center development sites? - Access to power is a significant constraint for data center land development [54] Question: What is the outlook for office leasing? - Management sees broad-based growth in office leasing, with a resurgence in gateway markets [56][62]